What is the appropriate workup for an adult with elevated aspartate aminotransferase (AST) of 112 U/L and alanine aminotransferase (ALT) of 153 U/L?

Workup for AST 112 and ALT 153

For an adult with AST 112 U/L and ALT 153 U/L (mild hepatocellular injury pattern), begin with targeted serologic testing for common causes: viral hepatitis panel (hepatitis A IgM, hepatitis B surface antigen and core antibody IgM, hepatitis C antibody), metabolic panel including fasting glucose and lipid profile, alcohol history, complete medication review, iron studies (ferritin and transferrin saturation), and abdominal ultrasound. 1, 2

Pattern Recognition and Classification

Your transaminase elevations represent mild hepatocellular injury (less than 5 times the upper limit of normal) with an ALT-predominant pattern (ALT > AST), which is the most common presentation in clinical practice 1. The ALT:AST ratio <1 suggests metabolic liver disease rather than alcohol-related injury, where the ratio is typically >2 1.

Initial Laboratory Workup

First-Tier Testing (Order Immediately):

• Viral hepatitis serologies: Hepatitis A IgM, HBsAg, hepatitis B core antibody IgM, hepatitis C antibody (consider HCV-RNA if high suspicion) 3, 2
• Metabolic assessment: Fasting glucose, hemoglobin A1c, lipid panel, BMI calculation 4, 1
• Iron studies: Serum ferritin and transferrin saturation to screen for hereditary hemochromatosis 5, 2
• Complete medication and supplement review: Including over-the-counter medications and herbal supplements 1, 2
• Alcohol consumption history: Quantify drinks per week 4, 1

Second-Tier Testing (If First-Tier Negative):

• Autoimmune markers: ANA, smooth muscle antibody, immunoglobulin levels for autoimmune hepatitis 1, 2
• Ceruloplasmin and 24-hour urinary copper: For Wilson disease if age <40 years 6, 2
• Alpha-1 antitrypsin level and phenotype: Particularly if family history or early-onset disease 1, 2
• Thyroid function tests: TSH to exclude thyroid-related causes 1

Imaging

Abdominal ultrasound is the appropriate first-line imaging study 1. It effectively detects moderate-to-severe hepatic steatosis (>30% fat content) with 84.8% sensitivity and 93.6% specificity, though it may miss mild steatosis 1. Ultrasound also evaluates for biliary obstruction, liver masses, and cirrhosis features 1.

Risk Stratification for Fibrosis

Given your mild transaminase elevations, assess for metabolic dysfunction-associated steatotic liver disease (MASLD) risk factors 4:

High-Risk Groups Requiring Fibrosis Assessment:

• Type 2 diabetes
• Abdominal obesity plus ≥1 additional metabolic risk factor (hypertension, dyslipidemia, prediabetes)
• Age >50 years with metabolic syndrome

If high-risk features present, calculate FIB-4 score (age × AST / [platelet count × √ALT]) as the initial non-invasive fibrosis assessment 4. If FIB-4 suggests possible fibrosis, proceed to liver elastography (FibroScan) as the second step 4.

Common Pitfalls to Avoid

1. Don't assume normal ALT excludes significant liver disease: Up to 50% of patients with NAFLD have normal transaminases, and fibrosis can progress despite "normal" enzyme levels 7, 8

2. Don't rely solely on magnitude of elevation: The degree of transaminase elevation does not correlate with prognosis or disease severity 8. A patient with ALT 150 U/L from hepatitis C may develop cirrhosis, while someone with ALT >1000 U/L from acute hepatitis A typically recovers completely 8

3. Don't repeat tests waiting for normalization without investigation: This delays diagnosis of chronic conditions like NAFLD and hepatitis C where enzymes may fluctuate or normalize despite ongoing disease 8

4. Consider non-hepatic AST sources if AST >> ALT: Hemolysis, myopathy, thyroid disease, or strenuous exercise can elevate AST disproportionately 1, 9

Monitoring Strategy

• If initial workup negative: Repeat liver enzymes in 3-6 months with continued clinical monitoring 3, 8
• If chronic elevation persists (>6 months): Consider liver biopsy if diagnosis remains unclear or multiple etiologies possible 3, 2
• If metabolic syndrome present: Monitor annually even if enzymes normalize, as disease can progress with normal ALT 4, 7

When to Refer to Hepatology

• Persistent elevation >6 months despite addressing reversible causes 3
• Evidence of synthetic dysfunction (low albumin, elevated INR, thrombocytopenia) 7
• Clinical signs of chronic liver disease or portal hypertension 7
• Positive autoimmune markers or elevated ferritin >1000 μg/L 5, 2
• Age <40 with unexplained transaminase elevation (consider Wilson disease) 6